By REUTERS
NYT
With smart cancer diagnostics, one-stop-shop diabetes kits and AI systems to improve ambulance pick-ups for patients with chest pain, AstraZeneca aims to move from simply supplying drugs to become a broad healthcare provider in China.
Published date: September 19, 2018 at 08:05AM
Reuters
New York Times article
Няма коментари:
Публикуване на коментар